The European Lung Cancer Conference 2015 (ELCC 2015), is the most important conference in Europe for all clinical practitioners involved in the diagnostic work-up and treatment of lung cancer and other thoracic malignancies.
It brings together a unique community of medical professionals to facilitate the advancement of a personalised approach to the management of lung and other thoracic cancers and the implementation of new discoveries into clinical practice.
Fast facts: ELCC 2015
- Over 1400 international participants expected
- Specialists and key opinion leaders from all over the world in one place and as one community
- 13 educational sessions and one key note lecture running over four days
- An internationally-renowned faculty
- Seven Industry Satellite Symposia
- Vibrant commercial exhibition
- Excellent networking opportunities
Past attendance
ESMO gratefully acknowledges the valuable contribution the following organisations have made to the ELCC conferences over the years.
Past attendees | ||
Abbott Laboratories |
Agennix |
Astrazeneca |
Amgen |
Bayer Schering Pharma |
BMS |
Boehringer Ingelheim |
Cis Bio International |
Clovis Oncology |
Daiichi Sankyo Europe |
Eli Lilly |
Elsevier |
GE Healthcare |
GSK |
Karl Storz |
Merck Serono |
Microsulis Medical Ltd. |
MSD |
Novartis Oncology |
Olympus Medical Systems Europe |
Pfizer Oncology |
Qiagen |
Roche |
Rosetta Genomics |
Sanofi |
Varian Medical Systems |
Wisepress |
How can I participate in ELCC 2015?
At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our conferences.
Contact the ESMO Events Sponsorship Team for more details. We look forward to hearing from you!